Peter Duncan Backs Wider Prostate Cancer Therapy Access

Prostate cancer remains a major health concern for men in the UK, with around 57,900 new cases diagnosed every year, making it the most common cancer among men. (1^✔ ✔Trusted Source
Prostate cancer statistics

Go to source

)

As treatment options evolve, focal therapy is emerging as a targeted approach that aims to treat cancer while preserving healthy prostate tissue.

Peter Duncan’s Prostate Cancer Journey and Call for NHS Access to Focal Therapy

Former Blue Peter host Peter Duncan has spoken about his experience with prostate cancer treatment, describing focal therapy as a “complete success” and a life-changing option.

“It was a complete success, and I’ve only experienced very minor after-effects, allowing me to continue with my life as before. But as it stands, many men aren’t given the same chance I was, and that needs to change,” said the ex-Blue Peter TV star.

He is now urging the NHS to expand access to focal therapy so more eligible prostate cancer patients can benefit from advanced, targeted treatment approaches.

Unlike traditional treatments that may affect the entire prostate, focal therapy focuses on treating the specific areas affected by prostate cancer, aiming to reduce damage to healthy tissue and potentially lower the risk of side effects.

Who is Peter Duncan?

Peter Duncan, 72, is a British actor and former Blue Peter presenter who has spent decades entertaining audiences through television, theatre, and documentaries.

Diagnosed with prostate cancer in 2019, he underwent focal therapy and later became an advocate for this targeted treatment, urging wider NHS access to advanced prostate cancer care for eligible patients.

What Is Focal Therapy and How Can It Help Prostate Cancer Patients?

Focal therapy for prostate cancer is a minimally invasive treatment that uses targeted techniques to destroy cancerous areas within the prostate while preserving surrounding healthy tissue.

It is generally considered for selected men with localized prostate cancer where the disease is confined to specific areas.

The goal of prostate cancer focal therapy is to provide effective cancer control while helping maintain quality of life by reducing treatment-related complications.

Depending on the patient’s condition, focal therapy options may include techniques such as high-intensity focused ultrasound (HIFU), cryotherapy, or other targeted ablation methods.

With thousands of men diagnosed with prostate cancer in the UK every year, improving access to innovative treatments remains a key focus in cancer care.

Why Wider Access to Advanced Prostate Cancer Treatments Matters in the UK

Despite having a strong healthcare system, the UK faces challenges in expanding access to advanced prostate cancer treatments like focal therapy.

The treatment requires specialized equipment, trained experts, and advanced imaging, and it is suitable only for selected patients with localized prostate cancer.

However, the availability of focal therapy through the NHS remains limited, partly due to ongoing NICE evaluation and the need for more long-term evidence on its effectiveness and safety before wider approval. (2^✔ ✔Trusted Source
Focal therapy using high-intensity focused ultrasound for localised prostate cancer

Go to source)

Advocates like Peter Duncan believe wider access to focal therapy could give eligible prostate cancer patients more personalised treatment options with fewer side effects.

Advanced options like focal therapy may offer suitable patients more personalised treatment choices alongside established approaches such as surgery and radiotherapy.

What Is Prostate Cancer? Exploring New Advances in Treatment

Prostate cancer develops in the prostate gland and is one of the most common cancers affecting men, particularly those over 50.
Prostate cancer treatment depends on the stage and may include active surveillance, surgery, radiotherapy, and hormone therapy.

Newer approaches like focal therapy target only cancerous areas while preserving healthy tissue, aiming to reduce side effects.

Techniques such as HIFU and advanced MRI imaging are helping doctors provide more personalised prostate cancer care.

The Prostate Cancer UK Risk Checker (3^✔ ✔Trusted Source
Check your risk in 30 seconds

Go to source) helps men understand their risk based on factors such as age, family history, and ethnicity, and encourages those at higher risk to discuss testing options like a PSA blood test with their GP.

Peter Duncan’s journey highlights the importance of access to better cancer care. “Where there is hope, there is a way.” Advances in prostate cancer treatment are creating more options for patients.

References:

1. Prostate cancer statistics – (https:www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer)
2. Focal therapy using high-intensity focused ultrasound for localised prostate cancer – (https://www.nice.org.uk/guidance/htg667/chapter/1-Recommendations)
3. Check your risk in 30 seconds – (https://prostatecanceruk.org/risk-checker)